Tina Trdan Lušin

Evaluation of bisphenol A glucuronidation according to UGT1A1*28 polymorphism by a new LC–MS/MS assay

Tina Trdan Lušin, Robert Roškar, Aleš Mrhar · Toxicology · 2011 · 41 citations

Polyphenolics, Biochemistry, New Lc–ms/ms Assay +8

Influence of hepatic and intestinal efflux transporters and their genetic variants on the pharmacokinetics and pharmacodynamics of raloxifene in osteoporosis treatment

Tina Trdan Lušin, Aleš Mrhar, Bruno Stieger et al. · Translational research · 2012 · 32 citations

Genetic Variants, Osteoporosis Treatment, Intestinal Efflux Transporters +7

Organic anion transporting polypeptides OATP1B1 and OATP1B3 and their genetic variants influence the pharmacokinetics and pharmacodynamics of raloxifene

Tina Trdan Lušin, Bruno Stieger, Janja Marc et al. · Journal of Translational Medicine · 2012 · 26 citations · Full text

Raloxifene Glucuronidation in Human Intestine, Kidney, and Liver Microsomes and in Human Liver Microsomes Genotyped for the UGT1A1*28 Polymorphism

Tina Trdan Lušin, Jurij Trontelj, Aleš Mrhar · Drug Metabolism and Disposition · 2011 · 21 citations

Development of an Analytical Method for Determination of Related Substances and Degradation Products of Cabotegravir Using Analytical Quality by Design Principles

Lidija Kovač, Zdenko Časar, Tina Trdan Lušin et al. · ACS Omega · 2022 · 20 citations · Full text

Engineering, Cabotegravir Impurities, Antiviral Drug +23